MYB and adrenal cortex carcinoma: Furthermore, molecular studies have identified recurrent genetic alterations in ACC, such as chromosomal translocations involving the MYB and, less frequently, MYBL1 genes, which could serve as potential diagnostic markers or therapeutic targets [1].